3256
A. E. Okoronkwo et al. / Tetrahedron Letters 49 (2008) 3252–3256
ethyl acetate (20 mL) and washed with aqueous NH4Cl (20 mL) and
water (3 Â 20 mL). The organic phase was separated, dried over
MgSO4, and concentrated under vacuum. The residue was purified by
flash chromatography on silica gel using ethyl acetate/hexane as the
eluent. Selected spectral for 2a. Yield: 0.185 g (82%). 1H NMR:
(400 MHz, CDCl3): d 7.42–7.38 (m, 2H), 7.30–7.27 (m, 3H), 4.02–3.99
(t, 2H, J = 5.8 Hz), 3.01 (t, 2H, J = 5.8 Hz), 2.55 (sl, 1H). 13C NMR:
(100 MHz, CDCl3): d 131.45, 128.21, 128.19, 123.08, 99.42, 68.91,
61.14, 32.26.
acknowledged for a fellowship [to GZ, C.W. Nogueira, and
Okoronkwo (CNPq/TWAS)].
References and notes
1. Walter, R.; Schwartz, I. L.; Roy, J. Ann. N.Y. Acad. Sci. 1972, 192,
175–180.
2. Gunther, W. H. H. J. Org. Chem. 1967, 32, 3931.
¨
19. General procedure for the alkynyltelluroalcohols synthesis: To a two-
neck round-bottomed flask, under argon, containing a solution of
appropriated alkyne (2 mmol) in THF (6 mL) at À78 °C was added to
n-BuLi (0.8 mL of a 2.5 M solution in hexane; 2 mmol). The reaction
mixture was stirred for 30 min. After this the reaction was warmed to
0 °C and elemental tellurium (0.256 g; 2 mmol) was added. The
reaction was allowed to stir at reflux for 5 h. After this time, the
reaction was cooled to room temperature and then the appropriated
bromoalcohol (1 mmol) was added. The reaction mixture was allowed
to stir at room temperature for additional 12 h. After this time, the
mixture was diluted with ethyl acetate (20 mL) and washed with
saturated aqueous NH4Cl (20 mL) and water (3 Â 20 mL). The
organic phase was separated, dried over MgSO4, and concentrated
under vacuum. The residue was purified by flash chromatography on
silica gel using ethyl acetate/hexane as the eluent. Selected spectral for
(3c). Yield: 0.114 g (45%). 1H NMR: (400 MHz, CDCl3): d 4.03 (t,
2H, J = 6.3 Hz), 2.98 (t, 2H, J = 6.3 Hz), 2.60 (sl, 1H), 1.24 (s, 9H).
13C NMR: (100 MHz, CDCl3): d 121.19, 62.93, 31.06, 29.43, 28.79,
13.08.
20. (a) Vinegar, R.; Truax, J. F.; Selph, J. L.; Jonhston, P. R. Antagonism
of pain and hyperalgesia. Anti-inflammatory drugs. In Handbook of
Experimental Pharmacology, 50/II; Vane, J. R., Ferreira, S. H., Eds.;
Springer: Berlin, 1979; (b) Tjolsen, A.; Hole, K. Animal models of
analgesia. In The Pharmacology of Pain; Dieckson, A., Besson, J.-M.,
Eds.; Springer: Berlin, 1997.
21. (a) Zeni, G.; Ludtke, D. S.; Panatieri, R. B.; Braga, A. L. Chem. Rev.
2006, 106, 1032–1076; (b) Zeni, G.; Braga, A. L.; Stefani, H. A. Acc.
Chem. Res. 2003, 36, 731–738.
3. Dickson, R. C.; Tappel, A. L. Arch. Biochem. Biophys. 1969, 130,
547–550.
4. Sies, H. Free Radical Biol. Med. 1993, 14, 313–323.
5. Nogueira, C. W.; Zeni, G.; Rocha, J. B. T. Chem. Rev. 2004, 104,
6255–6286.
6. (a) Nicolaou, K. C.; Petasis, N. A. Selenium in Natural Products
Synthesis; CIS: Philadelphia, 1984; (b) Paulmier, C. Selenium
Reagents and Intermediates in Organic Synthesis; Pergamon: Oxford,
1986; (c) Wirth, T.; Organoselenium Chemistry—Modern Develop-
ments in Organic Synthesis, Top. Curr. Chem. 208, Springer:
Heidelberg, 2000; (d) Mugesh, G.; Singh, H. B. Acc. Chem. Res.
2002, 35, 226–236.
7. Wo¨hler, F.; Siemens, C. Ann. Chem. 1847, 61, 360–365.
8. Sharpless, K. B.; Lauer, R. F. J. Am. Chem. Soc. 1973, 95, 2697–2699.
9. (a) Huguet, J. L. Adv. Chem. Ser. 1967, 345–348; (b) Sharpless, K. B.;
Young, M. W.; Lauer, R. F. Tetrahedron Lett. 1973, 22, 1979–1982.
10. (a) Reich, H. J. J. Org. Chem. 1975, 40, 2570–2572; (b) Sharpless, K.
B.; Lauer, R. F. J. Am. Chem. Soc. 1972, 94, 7154–7155.
11. Sevrin, M.; Vanende, D.; Krief, A. Tetrahedron Lett. 1976, 30, 2643–
2646.
12. Sevrin, M.; Dumont, W.; Hevesi, L. D.; Krief, A. Tetrahedron Lett.
1976, 30, 2647–2650.
13. (a) Seebach, D.; Peleties, N. Chem. Ber. 1972, 105, 511–515; (b)
Seebach, D.; Beck, A. K. Angew. Chem., Int. Ed. Engl. 1974, 13, 806–
807; (c) Reich, H. J.; Shah, S. K. J. Am. Chem. Soc. 1975, 97, 3250–
3252.
14. Silveira, C. C.; Braga, A. L.; Vieira, A. S.; Zeni, G. J. Org. Chem.
2003, 68, 662–665.
22. Bioassay: The abdominal constriction was induced according to
procedures described previously by Coˆrrea23 and modified by
Nogueira24 and resulted in the contraction of the abdominal muscle
together with a stretching of the hind limbs in response to an
intraperitoneal injection of acetic acid (1.6%) at the time of the test.
Mice were pre-treated with compounds 2o and 2v (1–50 mg/kg) by
oral route, 30 min before the irritant injection. Control animals
received a similar volume of vehicle (10 ml/kg, canola oil). After the
challenge, mice were individually placed in separate boxes and the
abdominal constrictions were counted cumulatively over a period of
20 min. Antinociceptive activity was expressed as the reduction in the
number of abdominal constrictions, that is, the difference between
control animals (mice pre-treated with vehicle) and animals
pre-treated with the drug.
15. (a) Sun, A. M.; Huang, X. Synthesis 2000, 775–777; (b) Zeni, G.;
Stracke, M. P.; Lissner, E.; Braga, A. L. Synlett 2003, 1880–1882; (c)
Comasseto, J. V.; Menezes, P. H.; Stefani, H. A.; Zeni, G.; Braga, A.
L. Tetrahedron 1996, 52, 9702–9787.
16. Comasseto, J. V.; Ling, L. W.; Petragnani, N.; Stefani, H. A.
Synthesis 1997, 373–413.
17. Ganjian, I.; Lalezari, I.; Herbert, H. J. Heterocycl. Chem. 1985, 22,
857–858.
18. General procedure for the alkynylselenoalcohols synthesis: To a two-
neck round-bottomed flask, under argon, containing a solution of
appropriated alkyne (2 mmol) in THF (6 mL) at À78 °C was added to
n-BuLi (0.8 mL of a 2.5 M solution in hexane; 2 mmol). The reaction
mixture was stirred for 30 min. After this the reaction was warmed to
0 °C and elemental selenium (0.158 g; 2 mmol) was added. The
reaction was allowed to stir at room temperature until all Se0 has been
consumed (yellow solution), and then the appropriated bromoalcohol
(1 mmol) was added. The reaction mixture was allowed to stir at room
temperature for 12 h. After this time, the mixture was diluted with
23. Correˆa, C. R.; Kyle, D. J.; Chakravarty, S.; Calixto, J. B. Br. J.
Pharmacol. 1996, 117, 552–558.
24. Nogueira, C. W.; Quinhones, E. B.; Jung, E. A. C.; Zeni, G.; Rocha,
J. B. T. Inflamm. Res. 2003, 52, 56–63.